INSTITUTIONAL ASPECTS OF STATE REGULATION OF THE DIGITAL FINANCIAL INSTRUMENTS MARKET
Market Infrastructure · 30.03.2026 · (89) · 93-98
DOI: 10.32782/infrastruct89-15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Market Infrastructure, online erschienen am 30.03.2026. Verfasst von Dmytro Fedorchuk. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The article examines the institutional aspects of state regulation of the digital financial instruments market in the context of the digital transformation of the financial sector and the development of capital markets. It is substantiated that the rapid spread of financial technologies, including crypto-assets, tokenized assets, digital platforms, and algorithmic investment solutions, transforms the traditional functioning of financial markets and requires the formation of an effective regulatory framework. The institutional architecture of regulation, which includes international, national, and self-regulatory levels, is analyzed. The main models of regulation of digital financial instruments are identified, including centralized, fragmented, integrated, hybrid, and transitional approaches. It is determined that Ukraine is characterized by a transitional regulatory model based on the gradual harmonization of national legislation with European regulatory standards.
Zitieren
APA
Fedorchuk, D. (2026). INSTITUTIONAL ASPECTS OF STATE REGULATION OF THE DIGITAL FINANCIAL INSTRUMENTS MARKET. Market Infrastructure, 93-98. https://doi.org/10.32782/infrastruct89-15
Vancouver
Fedorchuk D. INSTITUTIONAL ASPECTS OF STATE REGULATION OF THE DIGITAL FINANCIAL INSTRUMENTS MARKET. Market Infrastructure. 2026:93-98. doi:10.32782/infrastruct89-15
BibTeX
@article{Fedorchuk2026,
author = {Fedorchuk, Dmytro},
title = {INSTITUTIONAL ASPECTS OF STATE REGULATION OF THE DIGITAL FINANCIAL INSTRUMENTS MARKET},
journal = {Market Infrastructure},
year = {2026},
number = {89},
pages = {93--98},
doi = {10.32782/infrastruct89-15}
}
EUVIMED